UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024642
Receipt number R000016378
Scientific Title Clinical evaluation of 5-ALA/SFC for cisplatin induced renal injury
Date of disclosure of the study information 2016/10/31
Last modified on 2021/05/06 10:34:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical evaluation of 5-ALA/SFC for cisplatin induced renal injury

Acronym

ALA/SFC-Study

Scientific Title

Clinical evaluation of 5-ALA/SFC for cisplatin induced renal injury

Scientific Title:Acronym

ALA/SFC-Study

Region

Japan


Condition

Condition

Unresectable gastric cancer

Classification by specialty

Gastroenterology Hematology and clinical oncology Gastrointestinal surgery
Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Clinical applying 5-aminolevulinic acid(5-ALA) as new renal failure prophylaxis for the cisplatin induced renal injury

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety of 5-ALA/SFC as the prevention of renal failure supplement

Key secondary outcomes

Renal failure depression effect


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Food

Interventions/Control_1

5-aminolevulinic acid

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

Unresectable gastric cancer case

Key exclusion criteria

Contraindication cases of S-1 or cisplatin administration

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Tomoki
Middle name
Last name Yamatuji

Organization

kawasaki medical school

Division name

general surgery

Zip code

700-8505

Address

2-6-1 nakasange kitaku okayama city japan

TEL

0862252111

Email

kosaka.r@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Tomoki
Middle name
Last name Yamatuji

Organization

kawasaki medical school

Division name

general surgery

Zip code

700-8505

Address

2-6-1 nakasange kitaku okayama city japan

TEL

0862252111

Homepage URL

https://g.kawasaki-m.ac.jp/dept/geka/ekigaku

Email

kosaka.r@med.kawasaki-m.ac.jp


Sponsor or person

Institute

kawasaki medical school

Institute

Department

Personal name



Funding Source

Organization

kawasaki medical school

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawasaki Medical School . Hospital Ethics Committee

Address

577 Matsushima, Kurashiki City, Okayama Prefecture

Tel

0864641076

Email

kmsrec@med.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

12

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 07 Month 01 Day

Date of IRB

2014 Year 07 Month 01 Day

Anticipated trial start date

2014 Year 07 Month 01 Day

Last follow-up date

2022 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 10 Month 31 Day

Last modified on

2021 Year 05 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016378


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name